Summary & Overview
HCPCS P2038: Mucoprotein (Seromucoid) Blood Test
HCPCS Level II code P2038 denotes a laboratory test for mucoprotein (seromucoid) in blood. This code identifies a specific medical-necessity procedure used to measure an acute-phase protein that can aid in diagnosing or monitoring inflammatory conditions. Nationally, standardized coding for such niche laboratory assays supports accurate claims processing, utilization tracking, and clinical documentation.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code's clinical purpose and billing context, along with expected areas of analysis such as payer coverage patterns, reimbursement benchmarks, and any pertinent policy or coding guidance. The publication also outlines typical sites of service and how the procedure fits into laboratory service lines.
The analysis targets administrators, billing professionals, and clinicians seeking clarity on the clinical role and billing classification of mucoprotein blood testing. It highlights where to expect this procedure in the care pathway, common claims considerations, and how consistent coding supports interoperability between clinical records and payer adjudication. Data not available in the input for associated taxonomies, ICD-10 diagnoses, related codes, and modifiers is noted for transparency.
Billing Code Overview
HCPCS Level II code P2038 describes mucoprotein, blood (seromucoid) as a medical necessity laboratory procedure. The service involves analysis of blood to measure mucoprotein (seromucoid) levels, typically performed for diagnostic or monitoring purposes in clinical contexts where acute-phase reactants or inflammatory markers are relevant.
-
Service type: Laboratory test (blood analysis)
-
Typical site of service: Clinical laboratory, hospital laboratory, or outpatient phlebotomy/collection site
Data not available in the input for associated taxonomies, ICD-10 diagnoses, related codes, and service line.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to an outpatient laboratory or hospital phlebotomy service with nonspecific systemic symptoms such as fever, malaise, weight loss, or suspected inflammatory disease where assessment of mucoprotein (seromucoid) level is requested as an adjunct inflammatory marker. The clinician (internal medicine, rheumatology, or infectious disease) orders P2038 for serum mucoprotein measurement to help evaluate acute-phase response or to follow known inflammatory conditions.
The clinical workflow: the provider places the laboratory order in the electronic health record specifying P2038. A certified phlebotomist obtains a blood specimen in the ambulatory clinic, hospital inpatient unit, or outpatient laboratory; samples are labeled and sent to the clinical laboratory. The laboratory performs the biochemical assay for mucoprotein (seromucoid) and reports a quantitative result to the ordering clinician. Results are interpreted alongside clinical findings and other inflammatory markers (for example, C-reactive protein or erythrocyte sedimentation rate) to support diagnosis, monitor disease activity, or assess response to therapy.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when billing only the physician interpretation portion of a laboratory test when applicable (rare for automated lab assays). |